Torsemide: Difference between revisions

(Created page with "==Administration== *Type: Loop diuretic *Dosage Forms: *Routes of Administration: IV, PO *Common Trade Names: Demadex ==Adult Dosing== ''40mg furosemide = 20mg torsemide...")
 
 
(3 intermediate revisions by 2 users not shown)
Line 1: Line 1:
==General==
*80-100% oral bioavailability as opposed to [[furosemide]]<ref>Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.</ref>
==Administration==
==Administration==
*Type: Loop diuretic
*Type: Loop [[diuretic]]
*Dosage Forms:  
*Dosage Forms:  
*Routes of Administration: IV, PO
*Routes of Administration: IV, PO
Line 6: Line 9:


==Adult Dosing==
==Adult Dosing==
''40mg [[furosemide]] = 20mg torsemide = 1mg [[bumetanide]]''
''40mg [[furosemide]] = 20mg torsemide = 1mg [[bumetanide]] = 50mg [[Ethacrynic acid]]''
*5-200 mg PO or IV daily. Titrate to effect by doubling dose
*5-200 mg PO or IV daily. Titrate to effect by doubling dose


Line 33: Line 36:
==Pharmacology==
==Pharmacology==
*Half-life: 2-4 hours
*Half-life: 2-4 hours
*Metabolism: P450
*Metabolism:[[P450]]
*Excretion: Renal
*Excretion: Renal



Latest revision as of 21:03, 15 January 2017

General

Administration

  • Type: Loop diuretic
  • Dosage Forms:
  • Routes of Administration: IV, PO
  • Common Trade Names: Demadex

Adult Dosing

40mg furosemide = 20mg torsemide = 1mg bumetanide = 50mg Ethacrynic acid

  • 5-200 mg PO or IV daily. Titrate to effect by doubling dose

Pediatric Dosing

Safety/efficacy not established

Special Populations

Renal dosing: no adjustment Hepatic dosing: no adjustment

Contraindications

  • Allergy to class/drug
  • Anuria

Adverse Reactions

Serious

  • Ventricular tachycardia
  • SJS/TEN
  • Ototoxicity

Common

  • Polyuria
  • Rhinitis

Pharmacology

  • Half-life: 2-4 hours
  • Metabolism:P450
  • Excretion: Renal

Mechanism of Action

  • Loop diuretic: interferes with Na/K/Cl cotransport system, inhibiting reabsorption of Na/Cl in the ascending limb of the loop of Henle

Comments

See Also

References

  1. Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.